Kelly Bertram

Kelly Bertram is a Senior Research Fellow in the Department of Neuroscience at Monash University and a Clinical Neurologist at Alfred Hospital. Specializing in Movement Disorders, their research focuses on Parkinson's disease, Atypical Parkinsonism (including Progressive Supranuclear Palsy and Multiple System Atrophy), and Dystonia. They contribute to UN Sustainable Development Goals through neurodegenerative disease research.

Education: MBBS from the University of Melbourne.

Current projects include clinical trials for treatments targeting Spinocerebellar Ataxia Type 2, Parkinson’s disease symptom management, and disease-modifying therapies for PSP. Recent work includes developing diagnostic protocols for atypical parkinsonian syndromes and investigating non-invasive brain stimulation effects on cognitive function in Parkinson’s patients.

No scientific awards are explicitly listed in the provided text.

Advising and grants: Lead investigator in multiple clinical trials and research projects since 2016, including sodium selenate trials and drug efficacy studies. Collaborates widely on neurodegenerative disease research.

Labs/teams: Affiliated with Monash University’s Movement Disorders research group, contributing to translational studies and clinical protocols.